TGFβ drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| ethanol group | regulates | TGFβ | — | 1 |
| TGFβ | interacts_with | ITGB8 | — | 2 |
Mentioned in (8)
Papers in which this entity is mentioned.
- Functional analysis of cancer-associated germline risk variants. (2025)
- MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. (2025)
- ENPP1 Immunobiology as a Therapeutic Target. (2023)
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- Macrophage Polarization States in the Tumor Microenvironment. (2021)
- B lymphocytes and cancer: a love-hate relationship. (2016)
- Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
- Functional consequences of developmentally regulated alternative splicing. (2011)
Merged raw entities (5)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| tgfβ | drug | 22 | 49 |
| tgfb1 | drug | 10 | 15 |
| tgf-beta | drug | 7 | 10 |
| tgfβ | gene | 4 | 4 |
| transforming growth factor beta | drug | 3 | 4 |